Invest in the Future of Alzheimer’s Research
Join ARTC in revolutionizing Alzheimer’s care. We’re positioned at the forefront of breakthrough treatments. Your investment is a commitment to transforming lives.
Welcome to Alzheimer’s Research & Treatment Center Investor Relations
About Alzheimer’s Resesach and Treatment Center
At Alzheimer’s Research & Treatment Center, we are dedicated to advancing Alzheimer’s research and treatment through world-class clinical trials, innovative therapies, and patient-focused care. As a leader in Alzheimer’s research investment, we aim to play a critical role in improving the understanding of Alzheimer’s disease and developing new treatment options that enhance the lives of individuals and families affected by cognitive decline.
Our commitment to scientific rigor and patient well-being drives us to push the boundaries of what is possible in Alzheimer’s care, with the goal of ultimately finding a cure for this devastating disease.
The Alzheimer’s Research Investment Opportunity
55M+
People affected by Alzheimer’s worldwide
3x
Expected growth by 2050
$20B+
Global drug market by 2027
#1
Leading clinical trial site globally
Why Invest in Alzheimer’s Research?
At Alzheimer’s Research & Treatment Center, we are advancing a diverse pipeline of drug advancements aimed at addressing various aspects of Alzheimer’s disease. These include:
1. A Growing Market with Unmet Need
Alzheimer’s disease is one of the most pressing global health crises, affecting over 55 million people worldwide, with numbers expected to triple by 2050. Despite advancements, there are still no effective cures or comprehensive treatments. The global Alzheimer’s drug market is projected to exceed $20 billion by 2027, driven by rising awareness, improved diagnostic technologies, and an increasing focus on neurodegenerative disease solutions.
Investment Opportunity
As the world leading clinical trial site and company dedicated to research and clinical trials in Alzheimer’s care, Alzheimer’s Research & Treatment Center is uniquely positioned in this growing market. Our innovative approach to both early-stage drug discovery and patient treatment offer unmatched investment potential.
3. Experienced Leadership and Expertise
Our leadership team brings years of clinical and research expertise, coupled with strong ties to the global healthcare community. Key strengths include:
✔ Clinical Expertise
Our doctors, neurologists, and clinical research coordinators specialize in Alzheimer’s care and clinical trial conduct.
✔ Partnerships with Global Research Institutions
We partner with leading pharmaceutical companies, healthcare systems, and small biotechnology groups, accelerating the pace of Alzheimer’s research and expanding our global footprint.
✔ Proven Track Record
Our documented exceptional enrollment across clinical research for many trials including Leqembi and Kisunla confirms our status as the top global contributor, laying a decisive groundwork for innovative treatment solutions.
2. Cutting-Edge Research and Innovation
At Alzheimer’s Research & Treatment Center, we are committed to pioneering novel therapeutic pathways and advancing the science of Alzheimer’s disease. With a robust industry pipeline and advanced research methodologies, our center is well-seated to bring breakthrough treatments from the lab to the clinic—and ultimately, to the market.
Our research teams partner with large pharmaceutical companies and biotech to focus on:
✔ Biomarker Discovery
Utilizing genomic, proteomic, and imaging technologies to identify biomarkers for early detection and personalized treatments.
✔ Drug Development
Leveraging high-throughput screening, analytics, and cutting-edge neuroimaging techniques to execute clinical trials designed to develop novel drugs and therapies.
✔ Clinical Trials
We are conducting clinical trials focused on improving disease-modifying treatments, neuroprotection, cognitive enhancement, and symptom management.
4. Patient-Centered Approach with a Strong Community Focus
Our center places the patient at the heart of everything we do. We offer a patient-first approach, ensuring that each individual receives comprehensive care while actively participating in clinical trials and research. This not only improves the lives of patients but provides invaluable data to further Alzheimer’s treatment and development.
We are also deeply committed to education and outreach, empowering communities to better understand the disease, available treatment options, and the importance of participation in clinical trials.
Why Invest in Alzheimer’s Research?
At Alzheimer’s Research & Treatment Center, we are advancing a diverse pipeline of drug advancements aimed at addressing various aspects of Alzheimer’s disease. These include:
1. A Growing Market with Unmet Need
Alzheimer’s disease is one of the most pressing global health crises, affecting over 55 million people worldwide, with numbers expected to triple by 2050. Despite advancements, there are still no effective cures or comprehensive treatments. The global Alzheimer’s drug market is projected to exceed $20 billion by 2027, driven by rising awareness, improved diagnostic technologies, and an increasing focus on neurodegenerative disease solutions.
Investment Opportunity
As the world leading clinical trial site and company dedicated to research and clinical trials in Alzheimer’s care, Alzheimer’s Research & Treatment Center is uniquely positioned in this growing market. Our innovative approach to both early-stage drug discovery and patient treatment offer unmatched investment potential.
2. Cutting-Edge Research and Innovation
At Alzheimer’s Research & Treatment Center, we are committed to pioneering novel therapeutic pathways and advancing the science of Alzheimer’s disease. With a robust industry pipeline and advanced research methodologies, our center is well-seated to bring breakthrough treatments from the lab to the clinic—and ultimately, to the market.
Our research teams partner with large pharmaceutical companies and biotech to focus on:
✔ Biomarker Discovery
Utilizing genomic, proteomic, and imaging technologies to identify biomarkers for early detection and personalized treatments.
✔ Drug Development
Leveraging high-throughput screening, analytics, and cutting-edge neuroimaging techniques to execute clinical trials designed to develop novel drugs and therapies.
✔ Clinical Trials
We are conducting clinical trials focused on improving disease-modifying treatments, neuroprotection, cognitive enhancement, and symptom management.
3. Experienced Leadership and Expertise
Our leadership team brings years of clinical and research expertise, coupled with strong ties to the global healthcare community. Key strengths include:
✔ Clinical Expertise
Our doctors, neurologists, and clinical research coordinators specialize in Alzheimer’s care and clinical trial conduct.
✔ Partnerships with Global Research Institutions
We partner with leading pharmaceutical companies, healthcare systems, and small biotechnology groups, accelerating the pace of Alzheimer’s research and expanding our global footprint.
✔ Proven Track Record
Our documented exceptional enrollment across clinical research for many trials including Leqembi and Kisunla confirms our status as the top global contributor, laying a decisive groundwork for innovative treatment solutions.
4. Patient-Centered Approach with a Strong Community Focus
Our center places the patient at the heart of everything we do. We offer a patient-first approach, ensuring that each individual receives comprehensive care while actively participating in clinical trials and research. This not only improves the lives of patients but provides invaluable data to further Alzheimer’s treatment and development.
We are also deeply committed to education and outreach, empowering communities to better understand the disease, available treatment options, and the importance of participation in clinical trials.
Our Alzheimer’s Clinical Trial Pipeline
At Alzheimer’s Research & Treatment Center, we are advancing a diverse pipeline of drug advancements aimed at addressing various aspects of Alzheimer’s disease. These include:
✔ Phase I Drug Trials
Focusing on novel therapeutic compounds that target beta-amyloid plaques, tau, neuroinflammation, gene therapy and synaptic dysfunction to name a few. ARTC had dedicated overnight phase I centers.
✔ Phase II–IV Drug Trials
Implementing early phase II and larger-scale, late-stage studies designed to confirm a drug’s safety and effectiveness in broad patient populations. After approval, to monitor long-term outcomes, real-world effectiveness, and unanticipated adverse events to support sustained regulatory and commercial success.
✔ Precision Medicine
Using genetic biomarkers and personalized treatment strategies to ensure that therapies are tailored to individual patient needs for maximum efficacy.
✔ Innovative Approaches
Exploring the potential of gene therapies, biologics, and immunotherapies to reverse or slow neurodegeneration.
Strategic Growth & Expansion
Our strategic vision includes expanding our research capabilities, scaling up our clinical trial center infrastructure to 3 Centers of Excellence specializing in Alzheimer’s Disease. In the coming years, we aim to:
1. Expand Clinical Trial Network
By opening additional trial sites, or centers of excellence in key global markets, we will accelerate recruitment, data collection, and global collaboration with pharma partners. Expand phase I capabilities with dedicated centers affording opportunity within our centers of excellence.
2. Enhance Data Analytics
Implementing methods to streamline research processes, improve outcomes, and provide actionable insights that will facilitate natural organic growth.
3. Diversify Revenue Streams
ARTC is actively seeking strategic partnerships with pharmaceutical companies and clinical trial collaborations in a unique innovative manner.
Why Invest in Alzheimer’s Research?
Proven Market Potential
With Alzheimer’s affecting millions of individuals with no cure yet available, the potential for high returns on investment in this sector is substantial.
Experienced and Resilient Team
Our leadership combines scientific rigor with proven business acumen. ARTC operational efficiencies are superior through KOL-led trial design and sophisticated recruitment strategies.
Commitment to Innovation
Our forward-thinking approach and dedication to cutting-edge Alzheimer’s science give us a competitive advantage in the field.
Patient-Centered Research
Our focus on patient well-being ensures our research aligns with true needs in the healthcare landscape, and that will never be placed second, patients will always be first.
Get Involved: Become an Investor in Alzheimer’s Reserach
Join us in the fight against Alzheimer’s. Your investment in Alzheimer’s Research & Treatment Center is more than just a financial opportunity—it’s a chance to be part of a movement that will redefine the future of Alzheimer’s care and treatment.
We invite you to discuss how you can become part of the revolution in Alzheimer’s research and treatment.
Nationally Recognized Treatment Center located in the heart of Palm Beach, Martin and Muscogee Counties.
Wellington Location
2767 S. State Road 7
Suite 300
Wellington, FL 33414
(561) 209-2401
Stuart Location
1111 SE Indian Street Suite 102
Stuart, FL 34997
(772) 675-1111
Columbus, GA Location
2122 Manchester Expy Suite A-002A
Columbus, GA 31904